<VariationArchive VariationID="1919082" VariationName="NM_003054.6(SLC18A2):c.216dup (p.Asp73fs)" VariationType="Duplication" Accession="VCV001919082" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2023-02-07" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1971522" VariationID="1919082">
      <GeneList>
        <Gene Symbol="SLC18A2" FullName="solute carrier family 18 member A2" GeneID="6571" HGNC_ID="HGNC:10935" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="117241114" stop="117279430" display_start="117241114" display_stop="117279430" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="119000583" stop="119038940" display_start="119000583" display_stop="119038940" Strand="+" />
          </Location>
          <OMIM>193001</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003054.6(SLC18A2):c.216dup (p.Asp73fs)</Name>
      <CanonicalSPDI>NC_000010.11:117244064:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="117244064" stop="117244065" display_start="117244064" display_stop="117244065" variantLength="1" positionVCF="117244064" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="119003575" stop="119003576" display_start="119003575" display_stop="119003576" variantLength="1" positionVCF="119003575" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <OtherNameList>
        <Name>1-BP DUP, 216A (1265323526)</Name>
      </OtherNameList>
      <ProteinChange>D73fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.119003576dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.119003576dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.117244065dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.117244065dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003054.6" sequenceAccession="NM_003054" sequenceVersion="6" change="c.216dup" MANESelect="true">
            <Expression>NM_003054.6:c.216dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003045.2" sequenceAccession="NP_003045" sequenceVersion="2" change="p.Asp73fs">
            <Expression>NP_003045.2:p.Asp73fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003054.6" sequenceAccession="NM_003054" sequenceVersion="6" change="c.216dupA" MANESelect="true">
            <Expression>NM_003054.6:c.216dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="193001.0004" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003054.6(SLC18A2):c.216dup (p.Asp73fs) AND not provided" Accession="RCV002594638" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003054.6(SLC18A2):c.216dup (p.Asp73fs) AND Brain dopamine-serotonin vesicular transport disease" Accession="RCV004577023" Version="1">
        <ClassifiedConditionList TraitSetID="48337">
          <ClassifiedCondition DB="MedGen" ID="C4303546">Brain dopamine-serotonin vesicular transport disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-12-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-02-07" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26539891</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31618753</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">36318270</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="48337" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="42322" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Brain dopamine-serotonin vesicular transport disease</ElementValue>
                <XRef ID="UoA-AB0245-1" DB="Applied Translational Genetics Group, University of Auckland" />
                <XRef ID="MONDO:0018130" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinsonism-dystonia, infantile, 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PARKINSONISM-DYSTONIA 2, INFANTILE-ONSET</ElementValue>
                <XRef Type="MIM" ID="618049" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRAIN MONOAMINE VESICULAR TRANSPORT DISEASE</ElementValue>
                <XRef Type="MIM" ID="618049" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PKDYS2</ElementValue>
                <XRef Type="MIM" ID="618049" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13594" />
                <XRef ID="13594" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="352649" DB="Orphanet" />
              <XRef ID="C4303546" DB="MedGen" />
              <XRef ID="MONDO:0018130" DB="MONDO" />
              <XRef Type="MIM" ID="618049" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7814448" SubmissionDate="2023-12-11" DateLastUpdated="2023-12-17" DateCreated="2023-12-17">
        <ClinVarSubmissionID localKey="193001.0004_PARKINSONISM-DYSTONIA, INFANTILE, 2" title="SLC18A2, 1-BP DUP, 216A (1265323526)_PARKINSONISM-DYSTONIA, INFANTILE, 2" />
        <ClinVarAccession Accession="SCV004175905" DateUpdated="2023-12-17" DateCreated="2023-12-17" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 Costa Rican sibs (family 21, patients 33-35), born to consanguineous parents, with infantile parkinsonism-dystonia-2 (PKDYS2; 618049), Saida et al. (2023) identified homozygosity for a 1-bp duplication (c.216dupA, NM_003054.6) in the SLC18A2 gene, resulting in a frameshift and premature termination (Asp73ArgfsTer11). The mutation was identified by whole-exome sequencing and confirmed by Sanger sequencing. The mutation was present in the gnomAD database at an allele frequency of 1.18 x 10(-5) and was not present in the UK Biobank database.</Attribute>
              <Citation>
                <CitationText>Saida, K., Maroofian, R., Sengoku, T., Mitani, T., Pagnamenta, A. T., Marafi, D., Zaki, M. S., O'Brien, T. J., Karimiani, E. G., Kaiyrzhanov, R., Takizawa, M., Ohori, S., and 75 others Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: a study in 42 affected individuals. Genet. Med. 25: 90-102, 2023.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="618049" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC18A2" />
          </GeneList>
          <Name>SLC18A2, 1-BP DUP, 216A (1265323526)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 216A (1265323526)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="193001.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PARKINSONISM-DYSTONIA, INFANTILE, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5639878" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="12709912|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002949511" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26539891</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31618753</ID>
          </Citation>
          <Comment>This variant is present in population databases (no rsID available, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Asp73Argfs*11) in the SLC18A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC18A2 are known to be pathogenic (PMID: 26539891, 31618753). This variant has not been reported in the literature in individuals affected with SLC18A2-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC18A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.119003575_119003576insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5639878" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7814448" TraitType="Disease" MappingType="Name" MappingValue="PARKINSONISM-DYSTONIA, INFANTILE, 2" MappingRef="Preferred">
        <MedGen CUI="C4303546" Name="Brain dopamine-serotonin vesicular transport disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

